Pernix Therapeutics Appoints Terence Novak As COO

(RTTNews) - Pernix Therapeutics Holdings, Inc. (PTX) said Monday that it has appointed Terence Novak as Chief Operating Officer.

Novak most recently served as President of Norwich Pharma Services where he established the company as a leader in the contract development and manufacturing industry focused on specialty pharmaceutical companies. Prior to Norwich, he served as President of North America and Chief Commercial Officer at Patheon, Inc. Prior industry leadership positions include President of DSM Pharmaceuticals, Vice President at Cytogen, Executive Vice President at Algos Pharmaceuticals, and Vice President at Innovex, a division of Quintiles, and various sales and marketing positions at Bristol-Myers Squibb.